Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-1996 | 02-1995 | 02-1994 | 02-1993 | 02-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 31,986 | 23,971 | 16,804 | 10,488 | 7,489 |
| Depreciation Amortization | 4,346 | 3,110 | 2,995 | 1,769 | 1,545 |
| Other Working Capital | -6,471 | -16,035 | -2,921 | -15,396 | -5,234 |
| Other Operating Activity | -296 | 2,059 | 654 | 408 | 1,797 |
| Operating Cash Flow | $29,565 | $13,105 | $17,532 | $-2,731 | $5,598 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,907 | -7,243 | -7,446 | -1,850 | -1,178 |
| Other Investing Activity | -2,627 | -2,698 | -253 | -319 | -323 |
| Investing Cash Flow | $-18,534 | $-9,941 | $-7,698 | $-2,169 | $-1,501 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 863 | 1,136 | 34,169 | 4,167 | -3,636 |
| Financing Cash Flow | $863 | $1,136 | $34,169 | $4,167 | $-3,636 |
| Beginning Cash Position | 49,153 | 44,854 | 851 | 1,584 | 1,123 |
| End Cash Position | 61,047 | 49,154 | 44,854 | 851 | 1,584 |
| Net Cash Flow | $11,894 | $4,299 | $44,003 | $-734 | $461 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,565 | 13,105 | 17,532 | -2,731 | 5,598 |
| Free Cash Flow | 29,565 | 13,105 | 17,532 | -2,731 | 5,598 |